Company Filing History:
Years Active: 2010
Title: Heike Rothfels: Innovator in Kinesin Inhibition
Introduction
Heike Rothfels is a prominent inventor based in Constance, Germany. She has made significant contributions to the field of biochemistry, particularly in the development of novel compounds for therapeutic applications. Her work focuses on the inhibition of Eg5 kinesin, a critical protein involved in cell division.
Latest Patents
Heike Rothfels holds a patent for "Benzothienopyridines for use as inhibitors of Eg5 kinesin." This patent describes compounds of the formula (1), where R1, R2, R3, R4, and X have specific meanings as indicated in the description. These compounds are recognized for their effective Eg5 inhibitory, anti-proliferative, and apoptosis-inducing activities. She has 1 patent to her name, showcasing her innovative approach to addressing complex biological challenges.
Career Highlights
Heike Rothfels is associated with 4SC AG, a company dedicated to the development of innovative therapies for cancer and autoimmune diseases. Her role at the company has allowed her to contribute to groundbreaking research and development efforts in the pharmaceutical industry.
Collaborations
Heike has collaborated with notable colleagues, including Matthias Vennemann and Thomas Baer. These partnerships have enhanced her research capabilities and fostered a collaborative environment for innovation.
Conclusion
Heike Rothfels exemplifies the spirit of innovation in the field of biochemistry. Her work on Eg5 kinesin inhibitors represents a significant advancement in therapeutic development. Through her patents and collaborations, she continues to make impactful contributions to science and medicine.